TN2015000310A1 - Formulation comprising benzothiazolone compound - Google Patents

Formulation comprising benzothiazolone compound

Info

Publication number
TN2015000310A1
TN2015000310A1 TN2015000310A TN2015000310A TN2015000310A1 TN 2015000310 A1 TN2015000310 A1 TN 2015000310A1 TN 2015000310 A TN2015000310 A TN 2015000310A TN 2015000310 A TN2015000310 A TN 2015000310A TN 2015000310 A1 TN2015000310 A1 TN 2015000310A1
Authority
TN
Tunisia
Prior art keywords
formulation
benzothiazolone compound
benzothiazolone
compound
hydroxybenzo
Prior art date
Application number
TN2015000310A
Other languages
English (en)
Inventor
Miloud Achour
Robin Alec Fairhurst
Arnaud Grandeury
Shinji Hatakeyama
Magdalena Koziczak-Holbro
Nicola Tufilli
Thomas Ullrich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2015000310A1 publication Critical patent/TN2015000310A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TN2015000310A 2013-02-28 2015-07-16 Formulation comprising benzothiazolone compound TN2015000310A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361770584P 2013-02-28 2013-02-28
PCT/IB2014/059270 WO2014132205A1 (fr) 2013-02-28 2014-02-26 Préparation contenant un composé de benzothiazolone

Publications (1)

Publication Number Publication Date
TN2015000310A1 true TN2015000310A1 (en) 2017-01-03

Family

ID=50238437

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2015000310A TN2015000310A1 (en) 2013-02-28 2015-07-16 Formulation comprising benzothiazolone compound

Country Status (31)

Country Link
US (1) US9623012B2 (fr)
EP (1) EP2961391B1 (fr)
JP (2) JP6230626B2 (fr)
KR (1) KR20150120386A (fr)
CN (1) CN104968337A (fr)
AU (1) AU2014222362B2 (fr)
BR (1) BR112015020059A2 (fr)
CA (1) CA2897565A1 (fr)
CL (1) CL2015001940A1 (fr)
CY (1) CY1119202T1 (fr)
DK (1) DK2961391T3 (fr)
EA (1) EA026914B1 (fr)
ES (1) ES2637802T3 (fr)
HK (1) HK1212213A1 (fr)
HR (1) HRP20171177T1 (fr)
HU (1) HUE034353T2 (fr)
IL (1) IL240495A0 (fr)
LT (1) LT2961391T (fr)
MA (1) MA38354B1 (fr)
MX (1) MX2015011290A (fr)
NZ (1) NZ709747A (fr)
PE (1) PE20151608A1 (fr)
PH (1) PH12015501701A1 (fr)
PL (1) PL2961391T3 (fr)
PT (1) PT2961391T (fr)
SA (1) SA515360952B1 (fr)
SG (1) SG11201505544RA (fr)
SI (1) SI2961391T1 (fr)
TN (1) TN2015000310A1 (fr)
WO (1) WO2014132205A1 (fr)
ZA (1) ZA201504863B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
CN106146428A (zh) * 2012-08-30 2016-11-23 诺华股份有限公司 作为β‑2肾上腺受体激动剂的苯并噻唑酮化合物的盐
LT2961391T (lt) * 2013-02-28 2017-07-25 Novartis Ag Kompozicija, apimanti benzotiazolono junginį

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
EP1631260A2 (fr) 2003-02-28 2006-03-08 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques a base d'un co-cristal
WO2005110990A1 (fr) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Heterocycles benzocondenses substitues par hydroxy utilises comme beta-agonistes pour le traitement de maladies respiratoires
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
DE102009003975A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Benzothiazolonderivate
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
LT2961391T (lt) * 2013-02-28 2017-07-25 Novartis Ag Kompozicija, apimanti benzotiazolono junginį

Also Published As

Publication number Publication date
EA026914B1 (ru) 2017-05-31
PE20151608A1 (es) 2015-11-19
HUE034353T2 (en) 2018-02-28
PH12015501701A1 (en) 2015-10-12
US9623012B2 (en) 2017-04-18
CA2897565A1 (fr) 2014-09-04
US20160000761A1 (en) 2016-01-07
CN104968337A (zh) 2015-10-07
JP6230626B2 (ja) 2017-11-15
NZ709747A (en) 2018-04-27
BR112015020059A2 (pt) 2017-07-18
JP2016510020A (ja) 2016-04-04
HK1212213A1 (en) 2016-06-10
EP2961391B1 (fr) 2017-05-17
DK2961391T3 (en) 2017-09-04
ES2637802T3 (es) 2017-10-17
WO2014132205A1 (fr) 2014-09-04
PT2961391T (pt) 2017-08-29
AU2014222362B2 (en) 2016-07-21
SA515360952B1 (ar) 2016-07-10
SI2961391T1 (sl) 2017-08-31
MA38354A1 (fr) 2016-02-29
KR20150120386A (ko) 2015-10-27
LT2961391T (lt) 2017-07-25
CY1119202T1 (el) 2018-02-14
AU2014222362A1 (en) 2015-07-23
HRP20171177T1 (hr) 2017-10-06
MX2015011290A (es) 2015-12-03
JP2018035186A (ja) 2018-03-08
CL2015001940A1 (es) 2015-10-30
IL240495A0 (en) 2015-09-24
EA201591577A1 (ru) 2015-12-30
PL2961391T3 (pl) 2017-10-31
ZA201504863B (en) 2016-06-29
SG11201505544RA (en) 2015-09-29
EP2961391A1 (fr) 2016-01-06
MA38354B1 (fr) 2016-09-30

Similar Documents

Publication Publication Date Title
IL244206A0 (en) A pharmaceutical preparation containing a pyrimidine compound as an active ingredient
IL246377A0 (en) Pharmaceutical preparations for oral administration
EP3082817A4 (fr) Compositions pour administration de médicaments
EP3089736A4 (fr) Compositions pharmaceutiques pour composés faiblement hydrosolubles
EP3038465A4 (fr) Formulation pharmaceutique orale d'omarigliptine
EP3085385A4 (fr) Composition pharmaceutique contenant de l'adalimumab
EP2961733A4 (fr) Composés à base de disulfure pour l'administration d'agents pharmaceutiques
EP3034082A4 (fr) Composition pharmaceutique pour traiter ou prévenir une maladie neuropsychiatrique, contenant des dérivés de flavone-6-c-glucose comme principes actifs
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
PL2988733T3 (pl) Kompozycja farmaceutyczna zawierająca krystaliczny macitentan
EP3076952A4 (fr) Compositions permettant une administration par voie orale d'agents bioactifs
EP3020417A4 (fr) Composition pharmaceutique à administrer par les voies respiratoires
EP3318259A4 (fr) Composition pharmaceutique stable pour administration par voie orale
PH12015501701A1 (en) Formulation comprising benzothiazolone compound
EP2995307A4 (fr) Composition pharmaceutique orale destinée à améliorer la tolérance à l'anoxie
EP2958594A4 (fr) Composition pharmaceutique pour administration transmuqueuse améliorée de benzodiazépines
TWI800759B (zh) 醫藥劑型
EP3290037A4 (fr) Composition pharmaceutique pour administration par voie orale
EP3064203A4 (fr) Composition pharmaceutique servant à la prévention ou au traitement de maladies hépatiques contenant comme constituant efficace un précurseur de plasmalogène, un plasmalogène ou un analogue de plasmalogène
ZA201604100B (en) Gastro-retentive oral pharmaceutical compositions
GB201407847D0 (en) Composition for the oral delivery of compounds
EP3082783A4 (fr) Composition pharmaceutique orale stable
EP2979698A4 (fr) Composition pharmaceutique pour administration orale
EP3162368A4 (fr) Composition pharmaceutique à administration orale
TN2015000058A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist